Drug Res (Stuttg) 2024; 74(09): 433-455
DOI: 10.1055/a-2379-6849
Review

Bioflavonoid Daidzein: Therapeutic Insights, Formulation Advances, and Future Directions

Shafiurrahman 1
Sana Ahmad
1   Department of Pharmacy, Integral University, Dasauli, Kursi road, Lucknow (U.P.)-India
,
Farogh Ahsan
1   Department of Pharmacy, Integral University, Dasauli, Kursi road, Lucknow (U.P.)-India
,
Javed Akhtar Ansari
1   Department of Pharmacy, Integral University, Dasauli, Kursi road, Lucknow (U.P.)-India
,
Tarique Mahmood
1   Department of Pharmacy, Integral University, Dasauli, Kursi road, Lucknow (U.P.)-India
,
Shahzadi Bano
2   Department of Chemistry, Integral University, Dasauli, Kursi road, Lucknow (U.P.)-India
,
Mo. Shahanawaz
1   Department of Pharmacy, Integral University, Dasauli, Kursi road, Lucknow (U.P.)-India
› Author Affiliations

Funding Source This research did not receive any specific grants from funding agencies in the public, commercial, or not-for-profit sectors.
Preview

Abstract

Bioflavonoids, are a diverse group of phytonutrients that are widely distributed in fruits, vegetables, grains, teas, and certain medicinal herbs. They are characterized by their antioxidant properties and play essential roles in plant biology, such as providing color to fruits and flowers, protecting plants from environmental stresses. Daidzein, a bioflavonoid classified under natural products, is sourced from plants like soybeans and legumes. It exists in forms such as glycosides and aglycones, with equol and trihydroxy isoflavone being key metabolites formed by gut bacteria. Known for its wide-ranging therapeutic potential, daidzein has shown effects on cardiovascular health, cancer, diabetes, skin conditions, osteoporosis, and neurodegenerative disorders. Its mechanisms include interaction with estrogen receptors, antioxidative and anti-inflammatory properties, and modulation of apoptosis and cell cycles. Recent advances in formulation technologies aimed at enhancing daidzeinʼs bioavailability and efficacy are critically evaluated, including nanoparticle-based delivery systems and encapsulation strategies. Researchers have developed advanced formulations like nanoparticles and liposomes to enhance daidzeinʼs solubility, stability, bioavailability, and targeted delivery. Considered a promising nutraceutical, daidzein warrants further exploration into its molecular actions and safety profile to fully realize its clinical potential. This review offers a succinct overview encompassing therapeutic benefits, chemical characteristics, historical uses, toxicology insights, recent advancements in delivery systems, and future directions for daidzein research.



Publication History

Received: 20 June 2024

Accepted: 29 July 2024

Article published online:
19 September 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany